European monoclonal antibodies market is estimated to grow at a CAGR of 7.2% during the forecast period. An increasing approval for monoclonal antibodies has been reported in the region, owing to the rising demand for novel monoclonal antibody therapies with higher safety and efficacy in the region. For instance, in June 2020, the European Commission has approved Sarclisa (isatuximab), a monoclonal antibody along with pomalidomide and dexamethasone (pom-dex) to treat adult patients suffering from relapsed and refractory multiple myeloma. These are intended for multiple myeloma patients who have received a minimum of two prior therapies such as a proteasome inhibitor and lenalidomide and have shown the progression of the condition on the last therapy.
As a monoclonal antibody, Sarclisa attaches to a particular epitope on the CD38 receptor of multiple myeloma cells. This approval offers a crucial additional therapeutic alternative and will offer a new treatment for myeloma patients who require new potential treatments as their disease has become refractory to their earlier treatment disease or has returned. Sarclisa along with pom-dex shown median progression-free survival of approximately one year. The launch of novel monoclonal antibodies therapies will lead to drive safety and effectiveness of the therapy, which in turn, will further accelerate the market growth.
To Request a Sample of our Report on European Monoclonal Antibodies Market: https://www.omrglobal.com/request-sample/european-monoclonal-antibodies-market
European Monoclonal Antibodies Market-Segmentation
By Source
- Murine
- Chimeric
- Human
- Humanized
By Application
- Cancer
- Infectious Diseases
- Auto-Immune Diseases
- Inflammatory Diseases
- Others
A full Report of European Monoclonal Antibodies Market is Available at: https://www.omrglobal.com/industry-reports/european-monoclonal-antibodies-market
European Monoclonal Antibodies Market– Segment by Country
- Germany
- UK
- France
- Spain
- Italy
Rest of Europe
Company Profiles
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Co.
- Hoffmann-La Roche AG
- Genmab A/S
- GlaxoSmithKline plc
- Innate Pharma S.A.
- Mylan N.V.
- Novartis AG
- Pfizer Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-monoclonal-antibodies-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
